iSpecimen Amends Series C Preferred Stock Terms for Reverse Stock Split Adjustments

summarizeSummary

iSpecimen Inc. filed an amendment to its Series C Convertible Non-Voting Preferred Stock terms, clarifying how conversion and floor prices will adjust in the event of a reverse stock split or similar transaction.

check_boxKey Events

• Amendment to Series C Preferred Stock

  iSpecimen Inc. filed an Amended Certificate of Designation for its Series C Convertible Non-Voting Preferred Stock on January 16, 2026.

• Clarification of Conversion Terms

  The amendment clarifies that both the Conversion Price and Floor Price of the Series C Preferred Stock will be proportionately adjusted upon any reverse stock split, share combination, or similar transaction affecting common stock.

• Impact on Future Dilution

  This clarification is significant for understanding potential future dilution and the rights of preferred stockholders, especially given the common occurrence of reverse stock splits in micro-cap companies.

auto_awesomeAnalysis

This 8-K/A filing is important as it clarifies the terms of the Series C Convertible Non-Voting Preferred Stock, specifically regarding adjustments to the conversion price and floor price in the event of a reverse stock split or share combination. For a micro-cap company like iSpecimen, reverse stock splits are a common mechanism to maintain stock exchange listing, making these preferred stock terms highly relevant for understanding potential future dilution and the rights of preferred shareholders. The amendment ensures proportionate adjustments, providing clarity and protection for preferred stockholders in such scenarios.